Ten years on, Facebook remains an important channel through which pharma can engage with patients. What has been learned in that time and how have communication strategies evolved within the... Read more
Andrew McConaghie reports on contrasting views on 2014's merger and acquisition rollercoaster ride, and the forces propelling it.
The annual pharma / biotech sector conference hosted by the Financial Times usually yields... Read more
AstraZeneca (AZ) predicted yesterday that its "industry-leading" cancer portfolio would account for a quarter of its revenues in 2023 and is now considered its sixth growth platform.Just six months ago... Read more